Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

10 May 2010 07:00

RNS Number : 5791L
Tarsus Group PLC
10 May 2010
 



 

 

 

TARSUS GROUP plc

 

Interim Management Statement

 

Tarsus Group Plc ("Tarsus" or "the Group"), the international business-to-business media group, is today publishing its Interim Management Statement relating to the period from the publication of its Preliminary Results on 8 March 2010 to 9 May 2010.

 

Trading Performance

 

Trading for the period has been in line with the Board's expectations. A summary of major developments includes:

 

§ US - continued recovery & momentum

 

The Medical division continues to gain momentum. The April Orlando event produced revenues well ahead of last year, driven by very strong growth from its education programmes. Exhibition and conference revenues also grew for the first time in 18 months.

 

§ France - management action retains margins within expectations

 

A number of small exhibitions have taken place in France since 8 March. As expected, the declining revenue trends experienced in the second half of 2009 have continued into the first half of 2010. Strong cost management has resulted in margins remaining within our expectations.

 

§ Emerging Markets

 

No material events have taken place since 8 March.

 

Financial Position

 

There have been no significant changes to the financial position of the Group since the publication of the Preliminary Results on 8 March 2010.

 

Outlook

 

At our preliminary results at the start of March we announced the launch of "Project 50/13" to accelerate our scale in Emerging Markets. Our business infrastructure in the region is now established and Tarsus has a much improved platform within Asia and the Middle East from which to continue to drive strong growth.

 

As in previous years, the Group's revenues remain heavily second-half weighted and, overall, forward bookings remain at a similar level to 2009.

 

The French portfolio is weighted towards the 4th quarter of the year and we are now seeing signs of stabilisation in that market, with forward bookings for 4th quarter events at similar levels to last year. Given the current economic outlook for Europe, we continue to remain cautious.

 

US sales are strong and ahead of 2009, driven mainly by our Off-Price (discount clothing) and Medical divisions. Labelexpo America's sales are marginally behind the previous edition, owing to smaller exhibitors booking later in the cycle.

 

In the Emerging Markets division, the Group's largest event this year is MEBA (business aviation) which takes place in Dubai for which forward bookings are well ahead of the previous cycle.

 

Our view of trading for 2010 is unchanged with long term exhibition trends intact. The recovery in the US economy is benefiting our business in that market and we are seeing good growth prospects and opportunities in Emerging Markets. Our strong brands, diversified portfolio of market leading events and increased focus on Emerging Markets leave Tarsus well positioned for the future.

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

 

Media:

 

Madano Partnership

Matthew Moth 020 7593 4000

 

Investors/Analysts:

 

IRfocus

Neville Harris 020 7593 4015

 

Scott Harris

Stephen Scott, Jeremy Wiseman 020 7653 0030

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKKODKABKDOPK
Date   Source Headline
3rd Nov 20087:00 amRNSInterim Management Statement
31st Oct 200812:35 pmRNSResults of Court Meeting and General Meeting
16th Oct 20084:15 pmRNSHolding(s) in Company
8th Oct 20083:38 pmRNSIntroduction of a new UK-listed holding company
26th Sep 20087:00 amRNSAdditional Listing
19th Aug 20082:39 pmRNSHolding(s) in Company
15th Aug 20081:54 pmRNSDirector/PDMR Shareholding
11th Aug 20083:37 pmRNSDirector/PDMR Shareholding
1st Aug 200810:01 amRNSTotal Voting Rights - Replace
31st Jul 20086:22 pmRNSInterim Results - Replacement
31st Jul 20087:00 amRNSInterim Results
31st Jul 20087:00 amRNSTotal Voting Rights
24th Jul 20082:00 pmRNSNotice of Results
16th Jul 20082:57 pmRNSPDMR Shareholding & Additiona
7th Jul 200811:06 amRNSHolding(s) in Company
2nd Jul 200810:43 amRNSHolding(s) in Company
30th Jun 200810:45 amRNSPDMR Shareholding & Additiona
30th Jun 20087:00 amRNSDirectorate Change
30th Jun 20087:00 amRNSTrading Statement
27th Jun 20083:30 pmRNSHolding(s) in Company
24th Jun 20086:26 pmRNSDirector/PDMR Shareholding
2nd Jun 200811:26 amRNSPDMR Shareholding & Additiona
30th May 200810:28 amRNSTotal Voting Rights
16th May 200812:11 pmRNSHolding(s) in Company
16th May 20087:00 amRNSDirector/PDMR Shareholding
24th Apr 20084:06 pmRNSHolding(s) in Company
23rd Apr 20089:41 amRNSAdditional Listing
17th Apr 20083:14 pmRNSAGM Statement
17th Apr 20087:00 amRNSInterim Management Statement
7th Apr 20084:29 pmRNSDirector/PDMR Shareholding
4th Apr 20084:50 pmRNSDirector/PDMR Shareholding
4th Apr 20084:48 pmRNSHolding(s) in Company
1st Apr 20085:33 pmRNSHolding(s) in Company
1st Apr 20084:45 pmRNSHolding(s) in Company
20th Mar 200812:02 pmRNSAnnual Report and Accounts
3rd Mar 20087:00 amRNSAcquisition
3rd Mar 20087:00 amRNSFinal Results
31st Jan 20085:15 pmRNSTotal Voting Rights
31st Jan 20085:12 pmRNSHolding(s) in Company
31st Jan 20085:12 pmRNSHolding(s) in Company
17th Jan 20085:21 pmRNSAdditional Listing
7th Jan 20087:00 amRNSTrading Statement
20th Nov 200710:56 amRNSAdditional Listing
12th Nov 20077:00 amRNSJoint Venture
12th Nov 20077:00 amRNSAcquisition
2nd Nov 200711:56 amRNSAdditional Listing
1st Nov 20073:37 pmRNSTotal Voting Rights
26th Oct 20071:55 pmRNSHolding(s) in Company
23rd Oct 200711:52 amRNSAdditional Listing
23rd Oct 200711:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.